<doc>
  <docmeta id="113sres368ats">
    <bill congress="113" type="sres" number="368" version="ats"/>
    <revision size="4848" annotations="0" status="complete" id="4" commit-time="2014-08-11T18:47:48Z" committer="mnewby" doc="113sres368ats/4.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <resolution xmlns:cato="http://namespaces.cato.org/catoxml" public-private="public" resolution-stage="Agreed-to-Senate" resolution-type="senate-resolution" star-print="no-star-print">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 SRES 368 ATS: Designating February 28, 2014, as “Rare Disease Day”.</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. Senate</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-02-27</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">III</distribution-code>
		<congress display="yes">113th CONGRESS</congress>
		<session display="yes">2d Session</session>
		<legis-num>S. RES. 368</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action display="yes">
			<action-date date="20140227">February 27, 2014</action-date>
			<action-desc>
        <sponsor name-id="S307">Mr. Brown</sponsor> (for himself, <cosponsor name-id="S317">Mr. Barrasso</cosponsor>, <cosponsor name-id="S318">Mr. Wicker</cosponsor>, <cosponsor name-id="S337">Mr. Coons</cosponsor>, <cosponsor name-id="S330">Mr. Bennet</cosponsor>, <cosponsor name-id="S316">Mr. Whitehouse</cosponsor>, <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>, <cosponsor name-id="S295">Mr. Pryor</cosponsor>, and <cosponsor name-id="S366">Ms. Warren</cosponsor>) submitted the following resolution; which was considered and agreed to</action-desc>
		</action>
		<legis-type>RESOLUTION</legis-type>
		<official-title display="yes">Designating February 28, 2014, as <quote>Rare Disease Day</quote>.</official-title>
	</form>
	<preamble>
		<whereas>
      <text>Whereas a rare disease or disorder is one that affects a small number of patients – in the United
			 States, typically less than 200,000 individuals annually;</text>
    </whereas>
    <whereas>
      <text>Whereas as of the date of approval of this resolution, nearly 7,000 rare diseases affect
			 approximately 30,000,000 people in the United States and their families;</text>
    </whereas>
    <whereas>
      <text>Whereas children with rare genetic diseases account for more than half of the population affected
			 by rare diseases in the United States;</text>
    </whereas>
    <whereas>
      <text>Whereas many rare diseases are serious, life-threatening, and lack an effective treatment;</text>
    </whereas>
    <whereas>
      <text>Whereas great strides have been made in research and treatment for rare diseases as a result of the
			 <cato:entity entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/97/414">
          <cato:entity-ref entity-type="public-law" value="public-law/97/414">Public Law 97–414</cato:entity-ref>
        </external-xref>)</cato:entity>;</text>
    </whereas>
    <whereas>
      <text>Whereas the <cato:entity-ref entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> has made great strides in involving the patient in the
			 drug review process as part of its Patient-Focused Drug Development
			 program, an initiative that originated in the <cato:entity entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Food and Drug Administration Safety and Innovation Act">Food and Drug Administration
			 Safety and Innovation Act</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/112/144">
          <cato:entity-ref entity-type="public-law" value="public-law/112/144">Public Law 112–144</cato:entity-ref>
        </external-xref>)</cato:entity>;</text>
    </whereas>
    <whereas>
      <text>Whereas a third of all treatments approved by the <cato:entity-ref entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> in 2013 were orphan
			 products intended to treat rare diseases;</text>
    </whereas>
    <whereas>
      <text>Whereas lack of  access to effective treatments and difficulty in obtaining reimbursement for
			 life-altering, and even life-saving, treatments still exist and remain
			 significant challenges for the rare disease community and their families;</text>
    </whereas>
    <whereas>
      <text>Whereas rare diseases and conditions include epidermolysis bullosa, progeria, sickle cell anemia,
			 spinal muscular atrophy (SMA), Duchenne muscular dystrophy (DMD),
			 Tay-Sachs, cystic fibrosis, pulmonary fibrosis, many childhood cancers,
			 and
			 fibrodysplasia
			 ossificans progressiva;</text>
    </whereas>
    <whereas>
      <text>Whereas people with rare diseases experience challenges that include difficulty in obtaining
			 accurate diagnoses, limited treatment options, and difficulty finding
			 physicians or treatment centers with expertise in their diseases;</text>
    </whereas>
    <whereas>
      <text>Whereas the rare disease community made great strides in 2013, including the passage of the
			 <cato:entity entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="National Pediatric Research Network Act">National Pediatric Research Network Act</cato:entity-ref> (<external-xref legal-doc="public-law" parsable-cite="pl/113/55">
          <cato:entity-ref entity-type="public-law" value="public-law/113/55">Public Law 113–55</cato:entity-ref>
        </external-xref>)</cato:entity>, which calls
			 special attention to rare diseases and directs the <cato:entity-ref entity-id="7529" entity-type="federal-body">National Institutes of
			 Health</cato:entity-ref> to facilitate greater collaboration among researchers;</text>
    </whereas>
    <whereas>
      <text>Whereas both the <cato:entity-ref entity-id="7524" entity-type="federal-body">Food and Drug Administration</cato:entity-ref> and the <cato:entity-ref entity-id="7529" entity-type="federal-body">National Institutes of Health</cato:entity-ref> have
			 established special offices to advocate for rare disease research and
			 treatments;</text>
    </whereas>
    <whereas>
      <text>Whereas the National Organization for Rare Disorders, an organization established in 1983 to
			 provide services to and advocate on behalf of patients with rare diseases,
			 remains a critical public voice for people with rare diseases;</text>
    </whereas>
    <whereas>
      <text>Whereas 2013 marked the 30th anniversary of the <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref> and the National Organization for
			 Rare Disorders;</text>
    </whereas>
    <whereas>
      <text>Whereas the National Organization for Rare Disorders sponsors Rare Disease Day in the United States
			 to increase public awareness of rare diseases;</text>
    </whereas>
    <whereas>
      <text>Whereas Rare Disease Day is observed each year on the last day of February;</text>
    </whereas>
    <whereas>
      <text>Whereas Rare Disease Day is a global event, first observed in the United States on February 28,
			 2009, and observed in 60 countries in 2013; and</text>
    </whereas>
    <whereas>
      <text>Whereas Rare Disease Day is expected to be observed globally for years to come, providing hope and
			 information for rare disease patients around the world: Now, therefore, be
			 it</text>
		</whereas>
  </preamble>
	<resolution-body>
		<section display-inline="yes-display-inline" id="S1" section-type="undesignated-section">
      <enum/>
      <text>That the <cato:entity-ref entity-id="0010" entity-type="federal-body">Senate</cato:entity-ref>—</text>
			<paragraph id="id0eafdbb604d14ac3b0684f34d9e2d5a9">
        <enum>(1)</enum>
        <text>designates February 28, 2014, as <quote>Rare Disease Day</quote>;</text>
      </paragraph>
      <paragraph id="id54ed69507fbc4993b6efb5bf887fffa7">
        <enum>(2)</enum>
        <text>recognizes the importance of improving awareness and encouraging accurate and early diagnosis of
			 rare diseases and disorders; and</text>
      </paragraph>
      <paragraph id="id2c9c1613cb0d45efad6d1acada5ae2d5">
        <enum>(3)</enum>
        <text>supports a national and global commitment to improving access to, and developing new treatments,
			 diagnostics, and cures for rare diseases and disorders.</text>
			</paragraph>
    </section>
  </resolution-body>
</resolution>
</doc>